Inventor · disambiguated record
Johannes Tack
Also filed as: TACK JOHANNES · TACK JOHANNES W · TACK JOHANNES-WILHELM
17 granted patents·17 pending applications·916 citations·filing 1987–2023
95Inventor score
Top patents by PatentIndex Score
34 records- 0194US5676968ATransdermal therapeutic systems with crystallization inhibitorsSCHERING AG·Filed 1995·Granted Oct 14, 1997·162 cites·10 claims
- 0293US6294204B1Method of producing morphologically uniform microcapsules and microcapsules produced by this methodINHALE THERAPEUTIC SYST·Filed 1996·Granted Sep 25, 2001·158 cites·8 claims
- 0391US6787531B1Pharmaceutical composition for use as a contraceptiveSCHERING AG·Filed 2000·Granted Sep 7, 2004·70 cites·52 claims
- 0490US5071657ADevice for transdermal administration of active medicinal agentsSCHERING AG·Filed 1990·Granted Dec 10, 1991·167 cites·23 claims
- 0588US6572894B2Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this processACTIPAC BIOSYSTEMS GMBH·Filed 2001·Granted Jun 3, 2003·42 cites·14 claims
- 0687US5788984AGestodene-containing agent for transdermal administrationSCHERING AG·Filed 1995·Granted Aug 4, 1998·95 cites·38 claims
- 0779US7258871B2Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease statesNEUROBIOTEC GMBH·Filed 2001·Granted Aug 21, 2007·13 cites·36 claims
- 0877US4814175ANifedipine combination preparationSCHERING AG·Filed 1987·Granted Mar 21, 1989·56 cites·6 claims
- 0971US5730954APreparation comprising cavitate- or clathrate-forming host/guest complexes as contrast agentSCHERING AG·Filed 1994·Granted Mar 24, 1998·42 cites·15 claims
- 1067US5798338ASolid dosage forms that contain clathrates of 17α-ethinyl estradiolSCHERING AG·Filed 1995·Granted Aug 25, 1998·47 cites·14 claims
- 1166US7087078B2Tubular vascular implants (stents) and methods for producing the sameSCHERING AG·Filed 2001·Granted Aug 8, 2006·15 cites·18 claims
- 1263US2014050794A1Pharmaceutical composition for use as a contraceptiveBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1362US6177416B1OxyiminopregnancarbolactonesSCHERING AG·Filed 1997·Granted Jan 23, 2001·17 cites·23 claims
- 1456US5286494AMedicinal agents with sustained actionSCHERING AG·Filed 1991·Granted Feb 15, 1994·27 cites·11 claims
- 1555US2009325997A1Pharmaceutical Compositions For The Treatment Of Capillary ArteriopathyERGONEX PHARMA GMBH·Filed 2007·Application pending·0 cites
- 1655US2005214353A1Transdermal therapeutic systemHOROWSKI REINHARD·Filed 2005·Application pending·0 cites
- 1753US2025170076A1Novel kit of pharmaceutical preparations for the treatment of neurodegenerative diseasesBERLIREM GMBH·Filed 2023·Application pending·0 cites
- 1853US2015072939A1Lisurid, terguride and derivatives thereof for use in the prophylaxis and/or treatment of fibrotic changesSINOXA PHARMA GMBH·Filed 2014·Application pending·0 cites
- 1950US9695173B2Pharmaceutical compositions for the treatment of capillary arteriopathyREITER RUDOLF·Filed 2012·Granted Jul 4, 2017·0 cites·11 claims
- 2050US2005220855A1Transdermal therapeutic systemHOROWSKI REINHARD·Filed 2005·Application pending·0 cites
- 2149US2003087913A1Solid pharmaceutical agent formulation for a piperazine urea derivativeSCHERING AG·Filed 2002·Application pending·0 cites
- 2248US2004028723A1Transdermal therapeutic system for treating restless-legs-syndromeFiled 2001·Application pending·0 cites
- 2347US2014058108A1Lisuride, Terguride and Derivatives Thereof for Use in the Prophylaxis and/or Treatment of Fibrotic ChangesHOROWSKI REINHARD·Filed 2011·Application pending·0 cites
- 2446US2007243240A9Transdermal therapeutic systemWINDT-HANKE FRED·Filed 2005·Application pending·0 cites
- 2545US2004101550A1Transdermal therapeutic systemFiled 2001·Application pending·0 cites
- 2644US2010143475A1Transdermal therapeutic system with two-phase release profileTACK JOHANNES·Filed 2007·Application pending·0 cites
- 2743US2007134309A1Agent containing ergoline for transdermal applicationHOROWSKI REINHARD·Filed 2004·Application pending·0 cites
- 2839US2010086599A1Oral modified release formulationsKAIROSMED GMBH·Filed 2007·Application pending·0 cites
- 2937US7148207B2Oral fludara of high-purity formulation with quick release of active ingredientSCHERING AG·Filed 2002·Granted Dec 12, 2006·0 cites·12 claims
- 3035US11046640B2Water-soluble L-DOPA estersBERLIREM GMBH·Filed 2016·Granted Jun 29, 2021·0 cites·7 claims
- 3131US2019224153A1L-dopa derivatives for the treatment of neurological diseasesBERLIREM GMBH·Filed 2017·Application pending·0 cites
- 3231US2011124600A1Use of Dopamine partial agonists for treament of the restless leg syndrome and corresponding pharmaceutical preparationKRANDA KAREL·Filed 2003·Application pending·0 cites
- 3329US5432170AProcess for the production of semisolid preparations containing micronized active ingredientsSCHERING AG·Filed 1991·Granted Jul 11, 1995·5 cites·17 claims
- 3429US2001038823A1Microparticles, process for their production, and their use in ultrasound diagnosisFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johannes Tack files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →